Morning Market Movers
October 02, 2014 at 09:44 AM EDT
Esperion Therapeutics (NASDAQ: ESPR) shares climbed 18.55% to $28.95 after the company announced positive top-line Phase 2b results for ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|